Vulnerability · Published Aug 13, 2024 · Assigned by CERT-In

CVE-2024-2259Reflected XXS Vulnerability in InstaRISPACS Software

Medium 6.4

In plain English

A medium-severity cross-site scripting in InstaRISPACS from Meddiff Technologies. There are no confirmed reports of exploitation so far. The chance it is exploited in the next 30 days is estimated at 0.5% (higher than 43% of all known vulnerabilities).

Severity (CVSS 4.0)6.4Medium

Exploit odds (30 days)0.5%top 57.1% of all CVEs

Exploited in the wildNo reportsCISA SSVC: none

Attack toolingNoneno public tooling known

Official description

This vulnerability exists in InstaRISPACS software due to insufficient validation of user supplied input for the loginTo parameter in user login module of the web interface of the application. A remote attacker could exploit this vulnerability by sending a specially crafted input to the vulnerable parameter to perform reflected Cross Site Scripting (XSS) attacks on the targeted system.

Affected products (as reported)

Vendor	Product	Versions
Meddiff Technologies	InstaRISPACS	3.0.0<=4.0.0 Build 29<=5.0.0 Build 19

Weakness: CWE-79 · Vector: CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:A/VC:L/VI:L/VA:N/SC:H/SI:H/SA:H

References

https://www.cert-in.org.in/s2cMainServlet?pageid=PUBVLNOTES01&VLCODE=CIVN-2024-0241 third-party-advisory